How should medicines reimbursement work? The views of Spanish experts
Health Economics, Policy and Law · 2025
DOI: 10.1017/s174413312400029x ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Economics, Policy and Law, 2025. Verfasst von Juan Carlos Rejon-Parrilla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health Technology Assessment Area (AETSA), Andalusian Public Foundation Progress and Health (FPS), Seville, Spain. Hauptthemen laut MEDLINE: Reimbursement Mechanisms, Insurance, Health, Reimbursement. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Although the criteria that support reimbursement decisions for medicines are often set by legislation, as is the case in Spain, in many cases neither the definition nor the measurement methods for these criteria are provided. Our goal was to elicit the views of a large sample of Spanish technical specialists on how to evaluate each one of the criteria that inform pricing and reimbursement decisions in Spain. Professionals from various stakeholder groups involved in health economics, health technology assessment, and industry participated in a survey. Participants recommended that reimbursement decisions should take specific account of unmet medical need and rare diseases. Health benefit should be measured using quality-adjusted life-years. There should be an explicit cost-effectiveness threshold, and this threshold should take account of population groups and special situations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Technology Assessment Area (AETSA), Andalusian Public Foundation Progress and Health (FPS), Seville, Spain.
- Departamento de Economía Aplicada, Universidad de Granada, Campus de Cartuja, 18071, Granada, Spain.
- Biostatistics and Modelling Department, Outcomes'10, Castellón de la Plana, Spain.
- Andalusian School of Public Health, Granada, Spain.
- Instituto de Investigación Biosanitaria ibs., Granada, Spain.
- CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
ORCID-Profile: Juan Carlos Rejon-Parrilla, David Epstein
Förderung
- Ministerio de Ciencia e Innovación
Zitieren
APA
Rejon-Parrilla, J. C., Epstein, D., Pérez-Troncoso, D., & Espin, J. (2025). How should medicines reimbursement work? The views of Spanish experts. Health Economics, Policy and Law. https://doi.org/10.1017/s174413312400029x
Vancouver
Rejon-Parrilla JC, Epstein D, Pérez-Troncoso D, Espin J. How should medicines reimbursement work? The views of Spanish experts. Health Economics, Policy and Law. 2025. doi:10.1017/s174413312400029x
BibTeX
@article{RejonParrilla2025,
author = {Rejon-Parrilla, Juan Carlos and Epstein, David and Pérez-Troncoso, Daniel and Espin, Jaime},
title = {How should medicines reimbursement work? The views of Spanish experts},
journal = {Health Economics, Policy and Law},
year = {2025},
doi = {10.1017/s174413312400029x}
}
EUVIMED